A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature

Hormone Research in Pædiatrics
Shadab SalehpourAtoosa Gharib

Abstract

Constitutional delay of growth and puberty (CDGP) with short stature is one of the most common problems in pediatrics. We compared the effects of letrozole with that of oxandrolone on predicted adult height (PAH), puberty, bone mineral density, serum insulin-like growth factor 1 (IGF-1) and blood lipoproteins. In a prospective, double-blind, randomized, placebo-controlled clinical trial, 91 CDGP boys (12.6-14.6 years old) with predicted short stature were treated with letrozole (2.5 mg/day), oxandrolone (2.5 mg/day), or placebo, at the outpatient pediatric endocrine clinic of Mofid Children's Hospital in Tehran for 2 years. Letrozole differed from oxandrolone and placebo in significantly increasing PAH (p < 0.05), and slightly but significantly decreasing HDL-cholesterol. Oxandrolone, and to a lesser degree letrozole, significantly increased the height standard deviation score and bone age compared to placebo. This first randomized controlled clinical trial in CDGD teenage boys with predicted short stature shows that letrozole increases PAH more than oxandrolone and advances pubertal stage and bone mineralization less.

Citations

Apr 24, 2013·Nature Reviews. Endocrinology·Michael B Ranke
Mar 29, 2013·The New England Journal of Medicine·David B Allen, Leona Cuttler
Oct 11, 2011·Pediatric Clinics of North America·Nelly Mauras
Sep 12, 2015·Current Problems in Pediatric and Adolescent Health Care·Stacy L MeyerSusan Almazan
Jun 9, 2015·Best Practice & Research. Clinical Endocrinology & Metabolism·Jan M Wit, Wilma Oostdijk
Jun 24, 2015·Case Reports in Pediatrics·Susan R MendleyDebra R Counts
Nov 4, 2016·Physiological Reviews·Maria AlmeidaStavros C Manolagas
Oct 9, 2015·The Cochrane Database of Systematic Reviews·Niamh McGrath, Michael J O'Grady
Oct 26, 2011·Nature Reviews. Endocrinology·Jan M WitSusan B Nunez
Mar 27, 2012·European Journal of Endocrinology·Mauro BoronatFrancisco J Nóvoa
Jun 23, 2018·The Journal of Clinical Endocrinology and Metabolism·Shanlee M DavisJudith L Ross
Jan 29, 2014·Current Opinion in Endocrinology, Diabetes, and Obesity·Wylie C Hembree
Aug 20, 2014·The Journal of Clinical Endocrinology and Metabolism·E Kirk NeelyDiane I Suchet
Feb 17, 2017·Journal of Pediatric Endocrinology & Metabolism : JPEM·Jessica A Ferris, Mitchell E Geffner
Apr 27, 2019·Frontiers in Endocrinology·Tero VarimoMatti Hero
Jan 21, 2021·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Wang XiXueyan Wu
Jun 22, 2021·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·Jing LiuHuijuan Ma
Oct 1, 2018·Hormone Research in Pædiatrics·David B Allen
Jul 2, 2021·Indian Journal of Pediatrics·Rita Saroufim, Erica A Eugster

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.